Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) shares hit a new 52-week low during mid-day trading on Tuesday. The company traded as low as $291.11 and last traded at $297.05, with a volume of 423,671 shares changing hands. The stock had previously closed at $306.44.
Analyst Upgrades and Downgrades
Several analysts have weighed in on AXON shares. Argus boosted their price objective on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Needham & Company LLC lowered their price objective on Axon Enterprise from $750.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, November 6th. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a research report on Monday, November 2nd. UBS Group lifted their target price on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Finally, Northcoast Research increased their price objective on Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a research report on Tuesday, August 11th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $612.18.
Check Out Our Latest Stock Report on Axon Enterprise
Axon Enterprise Stock Down 2.2%
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The company had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. During the same quarter in the previous year, the company posted $1.17 EPS. The business’s quarterly revenue was up 27.8% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.
Insider Buying and Selling
In other news, insider Jeffrey C. Kunins sold 9,605 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president directly owned 296,974 shares of the company’s stock, valued at $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,397 shares of company stock worth $21,234,034 in the last three months. Corporate insiders own 4.20% of the company’s stock.
Institutional Trading of Axon Enterprise
Hedge funds and other institutional investors have recently made changes to their positions in the business. Keating Financial Advisory Services Inc. purchased a new stake in Axon Enterprise in the 2nd quarter worth approximately $31,000. Washington Trust Advisors Inc. increased its holdings in shares of Axon Enterprise by 1,300.0% during the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after purchasing an additional 65 shares in the last quarter. Morse Asset Management Inc acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $30,000. M & L Capital Management Ltd acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $30,000. Finally, Wealth Enhancement Trust Services Inc. purchased a new stake in Axon Enterprise during the third quarter worth $33,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
About Axon Enterprise
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
Featured Stories
- Five stocks we like better than Axon Enterprise
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
